Thousands of men with prostate cancer could be safely spared chemotherapy, after research found some were not helped by it.
A study of more than 2,000 men with advanced prostate cancer showed that on average, docetaxel chemotherapy improved five-year survival rates.
It was more effective in men with many metastases – meaning the cancer had spread – when diagnosed. But men with fewer metastases whose cancer was caught earlier did not benefit at all.
Load More
Yorumlar
Kalan Karakter: